T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...